Difference between revisions of "Estrogen receptor"

From Libre Pathology
Jump to navigation Jump to search
(create)
 
Line 7: Line 7:
*[[Breast carcinoma]] - most.
*[[Breast carcinoma]] - most.
**[[Ductal carcinoma in situ]] - most.
**[[Ductal carcinoma in situ]] - most.
**[[Invasive lobular breast carcinoma]] - all.
**[[Invasive lobular carcinoma]] - all.
**[[Invasive ductal carcinoma of breast]] - most.
**[[Invasive ductal carcinoma of the breast]] - most.
*[[Endometrial carcinoma]]s.
*[[Endometrial carcinoma]]s.



Revision as of 20:25, 23 June 2016

Estrogen receptor, abbreviated ER, is a common immunostain.

General

In the context of breast pathology it is a class II IHC test, as it is used for treatment decisions by itself.[1]

Positive

Negative

See also

References

  1. Torlakovic, EE.; Riddell, R.; Banerjee, D.; El-Zimaity, H.; Pilavdzic, D.; Dawe, P.; Magliocco, A.; Barnes, P. et al. (Mar 2010). "Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee/Immunohistochemistry: best practice recommendations for standardization of immunohistochemistry tests.". Am J Clin Pathol 133 (3): 354-65. doi:10.1309/AJCPDYZ1XMF4HJWK. PMID 20154273.